Tapahtumakalenteri

Program:

 

15:00 - 15:10 Introduction:  Single-cell resolution to immune responses

Anniina Färkkilä (University of Helsinki, Finland)

 

15:10 - 15:20 Spatial solutions for single-cell omics

Päivi Saavalainen (SCellex)

 

15:20 - 16:10 Profiling tumor immunity at single-cell level  

Prof. Bernd Bodenmiller (University of Zurich, Switzerland)

16:10- 16:20 Q&A

16:20 – 16:45 Panel Discussion: Single-cell pathology – Utopia or reality?

Panelists: Bernd Bodenmiller, Anniina Färkkilä, Päivi Saavalainen, Eevi Kaasinen

Session Chair: Heidi Haikala, Cancer IO

 

Biography for Dr. Bernd Bodenmiller:

Professor Bernd Bodenmiller was appointed Associate Professor of Quantitative Biomedicine in the Department of Biology. He holds a dual professorship with the University of Zurich. Bernd Bodenmiller's research investigates the mechanisms of cancer ecosystems. His work identified novel tumor and immune cell phenotypes associated with clinical features, signaling mechanisms leading to therapy resistance, and experimental and computational methods to image tissues in a highly multiplexed manner in situ. These methods are widely used by researchers and also in clinical studies. Bernd Bodenmiller has developed an excellent international network and has received several awards, including an ERC Starting Grant and an ERC Consolidator Grant. In addition, he is the founding director of the Department of Quantitative Biomedicine at the University of Zurich.

After his graduate studies in biochemistry at ETH Zurich and a PhD in the lab of Ruedi Aebersold (2004 to 2008), he continued his research with two postdoctoral positions in the Aebersold lab and the Nolan lab (Stanford). In 2013, he returned to Zurich where he obtained a SNSF assistant professorship at the Institute of Molecular Life Sciences (University of Zurich). Since 2019, Bernd Bodenmiller is the director of the Department of Quantitative Biomedicine (UZH).